Get started
Author

Aime Powell

Observed names: Aime Helene Powell, Powell, Aime
Observed institutions: Australian National University, St John of God Subiaco Hospital, The University of Western Australia, Cancer Australia, Australia New Zealand Gynaecological Oncology Group, The University of Notre Dame Australia
ORCID: 0000-0002-0728-1584
Observed ORCID: 0000-0002-0728-1584
OpenAlex ID: A5090048002
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
2019 · Paul A. Cohen, Aime Powell, et al. · Gynecologic Oncology · 120
PDF
Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer
2018 · Louise M. Stewart, Katrina Spilsbury, et al. · Cancer Epidemiology · 38
PDF
Morbidity after surgical management of cervical cancer in low and middle income countries: A systematic review and meta-analysis
2019 · Emma R. Allanson, Aime Powell, et al. · PLoS ONE · 17
PDF
Cervical screening approach of self-collection, point-of-care HPV testing, and same-day colposcopy among Aboriginal and Torres Strait Islander women in remote Western Australia (the PREVENT Project): an implementation study
2025 · Aime Powell, Lorraine Anderson, et al. · The Lancet Public Health · 11
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy
2020 · Paul A. Cohen, Yee Leung, et al. · Gynecologic Oncology · 10
Improved Risk Prediction in Human Papillomavirus–Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP)
2024 · Aime Powell, Anjelica Hodgson, et al. · International Journal of Gynecological Pathology · 7
PDF
Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study
2017 · Paul A Cohen, Alison Brand, et al. · BMJ Open · 5
PDF
Review of gynaecological cancer among Aboriginal and/or Torres Strait Islander people in Australia
2023 · Aime Powell, Ami Morseu-Diop, et al. · Journal of the Australian Indigenous HealthInfoNet · 4
PDF
Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data
2018 · Paul Cohen, Aime Powell, et al. · SSRN Electronic Journal · 3
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448]
2020 · Paul A. Cohen, Aime Powell, et al. · Gynecologic Oncology · 2
PDF
RANZCOG Fellows’ adherence to guidelines following cytological prediction of cervical adenocarcinoma‐in‐situ: Cause for concern?
2018 · Aime Powell, Paul A. Cohen, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 2
PR049/#741 Improved risk prediction in HPV-associated endocervical adenocarcinoma through assessment of binary silva pattern-based classification: international multicenter retrospective study of the international society of gynecological pathologists
2023 · Aime Powell, Anjelica Hodgson, et al. · International Journal of Gynecological Cancer · 1
PDF
990 Recurrent Pattern A HPV-Associated Endocervical Adenocarcinoma: Detailed Results from the International Society of Gynecological Pathologists Endocervical Adenocarcinoma Data Collection Project
2026 · Anjelica Hodgson, Aime Powell, et al. · Laboratory Investigation
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448
2021 · Paul A. Cohen, Aime Powell, et al. · Gynecologic Oncology
PDF
Excisional Treatment Comparison For In Situ Endocervical Adenocarcinoma (EXCISE): A Phase 2 Pilot Randomised Controlled Trial to Compare Histopathological Margins Status, Specimen Size and Fragmentation after Loop Electrosurgical Excision Procedure and Cold Knife Cone Biopsy
2020 · Paul Cohen, Yee Leung, et al. · SSRN Electronic Journal
Works count: 17
Citation count: 220
H-index: 6
I10-index: 5
Year
Topic
Type